I keep coming back to NCT04184622: 2539 participants, Week 0–Week 72, arms were placebo, 5 mg, 10 mg, and 15 mg. In real-world threads, 5 mg seems to be where a lot of people camp long-term. Is that because side effects, cost, or because it's enough?
I'm not asking for dosing advice—just curious whether the trial design tells us anything about who actually needed higher arms. My own tracking is flat lately, so I’m trying to separate noise from pattern.